Cheng Y, Chiang H
Neurol Sci. 2025; .
PMID: 40085320
DOI: 10.1007/s10072-025-08114-w.
Wang L, Han J, Fearnley L, Milton M, Rafehi H, Reid J
NPJ Parkinsons Dis. 2024; 10(1):219.
PMID: 39543161
PMC: 11564539.
DOI: 10.1038/s41531-024-00831-x.
Manganaro J, Emanuel K, Lamberty B, George J, Stauch K
Sci Rep. 2024; 14(1):23861.
PMID: 39394439
PMC: 11470019.
DOI: 10.1038/s41598-024-74775-w.
Sun Q, Li Y, Ning S
Sci Rep. 2024; 14(1):17028.
PMID: 39043798
PMC: 11266657.
DOI: 10.1038/s41598-024-67890-1.
Chen Z, Li W, Meng B, Xu C, Huang Y, Li G
iScience. 2024; 27(7):110243.
PMID: 39006478
PMC: 11246066.
DOI: 10.1016/j.isci.2024.110243.
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.
Vega-Benedetti A, Porcedda C, Ercoli T, Fusco G, Burgaletto C, Pillai R
J Neurol. 2024; 271(9):5916-5929.
PMID: 38985290
PMC: 11377674.
DOI: 10.1007/s00415-024-12554-3.
Pink1/Parkin deficiency alters circulating lymphocyte populations and increases platelet-T cell aggregates in rats.
Manganaro J, Emanuel K, Lamberty B, George J, Stauch K
Res Sq. 2024; .
PMID: 38854001
PMC: 11160909.
DOI: 10.21203/rs.3.rs-4431604/v1.
The immune system in Parkinson's disease: what we know so far.
Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark K, Ertan S
Brain. 2024; 147(10):3306-3324.
PMID: 38833182
PMC: 11449148.
DOI: 10.1093/brain/awae177.
Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson's disease: a 1-year observational study.
Arce-Sillas A, Alvarez-Luquin D, Leyva-Hernandez J, Montes-Moratilla E, Vivas-Almazan V, Perez-Correa C
J Neural Transm (Vienna). 2024; 131(8):901-916.
PMID: 38822829
DOI: 10.1007/s00702-024-02790-2.
Causal role of immune cells on risk of Parkinson's disease: a Mendelian randomization study.
Gu J, Qiao Y, Cong S
Front Aging Neurosci. 2024; 16:1368374.
PMID: 38586828
PMC: 10995297.
DOI: 10.3389/fnagi.2024.1368374.
Peripheral immune profile in drug-naïve dementia with Lewy bodies.
Umehara T, Mimori M, Kokubu T, Ozawa M, Shiraishi T, Sato T
J Neurol. 2024; 271(7):4146-4157.
PMID: 38581545
DOI: 10.1007/s00415-024-12336-x.
The role of CD56 NK cells in neurodegenerative disorders.
Rodriguez-Mogeda C, van Ansenwoude C, van der Molen L, Strijbis E, Mebius R, de Vries H
J Neuroinflammation. 2024; 21(1):48.
PMID: 38350967
PMC: 10865604.
DOI: 10.1186/s12974-024-03040-8.
Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson's Disease Patients and Healthy Controls.
Georgoula M, Ntavaroukas P, Androutsopoulou A, Xiromerisiou G, Kalala F, Speletas M
Int J Mol Sci. 2024; 25(3).
PMID: 38339069
PMC: 10855941.
DOI: 10.3390/ijms25031791.
Exploring the causal relationship between B lymphocytes and Parkinson's disease: a bidirectional, two-sample Mendelian randomization study.
Song J, Qin Y, Wang L, Quan W, Xu J, Li J
Sci Rep. 2024; 14(1):2783.
PMID: 38307922
PMC: 10837417.
DOI: 10.1038/s41598-024-53287-7.
Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
Huang J, Li B, Wei H, Li C, Liu C, Mi H
Sci Rep. 2024; 14(1):2167.
PMID: 38272954
PMC: 10810830.
DOI: 10.1038/s41598-024-52276-0.
Intruders or protectors - the multifaceted role of B cells in CNS disorders.
Aspden J, Murphy M, Kashlan R, Xiong Y, Poznansky M, Sirbulescu R
Front Cell Neurosci. 2024; 17:1329823.
PMID: 38269112
PMC: 10806081.
DOI: 10.3389/fncel.2023.1329823.
Epigenome-wide association study of peripheral immune cell populations in Parkinson's disease.
Andersen M, Leikfoss I, Brorson I, Cappelletti C, Bettencourt C, Toft M
NPJ Parkinsons Dis. 2023; 9(1):149.
PMID: 37903812
PMC: 10616224.
DOI: 10.1038/s41531-023-00594-x.
Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease.
Hepp D, van Wageningen T, Kuiper K, van Dijk K, Oosterveld L, Berendse H
Int J Mol Sci. 2023; 24(19).
PMID: 37834363
PMC: 10573398.
DOI: 10.3390/ijms241914915.
The role of immune cells in the course of Parkinson's disease.
He X, Wang R, Wang T
Ibrain. 2023; 7(2):146-151.
PMID: 37786903
PMC: 10529156.
DOI: 10.1002/j.2769-2795.2021.tb00077.x.
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?.
Furgiuele A, Pereira F, Martini S, Marino F, Cosentino M
Clin Transl Immunology. 2023; 12(10):e1469.
PMID: 37781343
PMC: 10540835.
DOI: 10.1002/cti2.1469.